SEATTLE (AP) — SEATTLE (AP) — Perspective Therapeutics, Inc. (CATX) on Monday reported a loss of $26 million in its third quarter.
The Seattle-based company said it had a loss of 35 cents per share.
The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share.
The isotope-based medical products maker posted revenue of $209,000 in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $300,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CATX at https://www.zacks.com/ap/CATX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
